Table 1.
Patient demographics
| Hypothermia (n = 27) | No hypothermia (n = 11) | |
|---|---|---|
| Age (years) | 61.4 ± 10.5 | 64.6 ± 10.9 |
| STEMI vs. NSTEMI (n) | 11 (40.7 %) vs. 16 (59.3 %) | 5 (45.5 %) vs. 6 (54.4 %) |
| LVF | ||
| Normal to mildly impaired (n) | 3 (11.1 %) | 2 (18.2 %) |
| Moderately impaired (n) | 9 (33.3 %) | 3 (27.3 %) |
| Highly impaired (n) | 15 (55.5 %) | 6 (54.5 %) |
| 3 vessel CAD (n) | 18 (66.7 %) | 7 (63.6 %) |
| Time to ROSC (min) | 24.7 ± 12.4 | 18.6 ± 12.2 |
| Discharge from hospital (n) | 16 (59.3 %) | 8 (72.7 %) |
| Neurologic outcome | ||
| CPC 1 and CPC 2 (n) | 10 (37.0 %) | 7 (63.6 %) |
| CPC 3 and CPC 4 (n) | 6 (22.2 %) | 1 (9.1 %) |
| Gastroesophageal reflux (mL) | 79.6 ± 127.3 | 203.0 ± 314.8 |
| Lysis or GPIIa/IIIb inhibitor treatment | ||
| Tenecteplase (n; time to measurement) | 3 (11.1 %); 30.8 ± 3.9 h | 2 (18.2 %); 31 ± 1.1 h |
| Eptifibatide (n; time to measurement) | 2 (7.4 %); 30.5 ± 2.1 h | 0 (0 %); n/a |
| Tirofiban (n; time to measurement) | 3 (11.1 %); 21.7 ± 1.5 h | 1 (9.1 %); 34 h |
| Dialysis | 0 | 1 (9.1 %) |
| Temp. on admission (°C) | 35.0 ± 1.0 | 35.6 ± 1.4 |
| Temp. at loading with ticagrelor (°C) | 34.5 ± 1.1 | 36.0 ± 1.4 |
CAD coronary artery disease, CPC cerebral performance category, Dialysis dialysis for acute or chronic kidney failure, LVF left ventricular function, ROSC return of spontaneous circulation, STEMI ST-elevation myocardial infraction, Temp. temperature